-
公开(公告)号:US20210278371A1
公开(公告)日:2021-09-09
申请号:US17261336
申请日:2019-07-11
Applicant: NPL Management Limited , The University of Strathclyde
Inventor: Witold Chalupczak , Rafal Gartman , Patrick Bevington
IPC: G01N27/82
Abstract: Disclosed herein is a method of detecting a material response. The method includes providing an oscillating primary magnetic field to cause a sample to produce a secondary magnetic field. The method also includes reducing the effect on an atomic magnetometer of components of the primary and secondary magnetic fields in a direction substantially orthogonal to a surface of the sample. The method also includes detecting the secondary magnetic field with the atomic magnetometer to detect the material response.
-
公开(公告)号:US11013100B2
公开(公告)日:2021-05-18
申请号:US16341039
申请日:2017-09-29
Applicant: University of Strathclyde
Inventor: Bernhard Hidding , Grace Manahan , Fahim Ahmad Habib , Paul Scherkl
Abstract: A method of accelerating charged particles in a plasma and an associated plasma accelerator and electromagnetic radiation source, the method including creating a region of non-uniform electric field within the plasma which propagates through the plasma; using the non-uniform electric field to accelerate a first plurality of charged particles in the direction of propagation of the region of non-uniform electric field; and once the accelerating first plurality of charged particles have propagated part-way through the plasma: adding a second plurality of charged particles to the plasma, such that the second plurality of charged particles propagates through the plasma, the second plurality of charged particles create a local distortion in the non-uniform electric field experienced by the accelerating first plurality of charged particles, and the local distortion in the non-uniform electric field propagates through the plasma with the accelerating first plurality of charged particles; and the method also including using the local distortion in the non-uniform electric field to accelerate the first plurality of charged particles in the direction of propagation of the region of non-uniform electric field.
-
公开(公告)号:US20200281468A1
公开(公告)日:2020-09-10
申请号:US16651449
申请日:2018-08-22
Applicant: University of Strathclyde
Inventor: Martin David Dawson , Keith Mathieson , Gabor Varkonyi , Jonathan McKendry
IPC: A61B5/00 , A61N1/372 , A61B5/04 , H04B10/114 , H04L7/00
Abstract: An interface or communications system for a neural probe, the interface or communications system comprising at least one probe interface, an optical communications interface and a processing system. The at least one probe interface is configured to interface with at least one neural probe so as to receive data collected by the probe. The processing system is configured to process the data from the at least one probe interface and provide the processed data to the optical communications interface. The optical communications interface is configured to communicate the processed data to a remote device, e.g. using optical wireless communications. The optical communications interface has the large bandwidth available that will allow the scaling up of recording sites from the neural probe without resulting in undue size, weight and/or power consumption.
-
24.
公开(公告)号:US20190070323A1
公开(公告)日:2019-03-07
申请号:US15765424
申请日:2016-09-29
Applicant: The US of America, as represented by the Secretary Dept. of Health and Human Servics , The University of Strathclyde
Inventor: Chintamani Atreya , Michelle Maclean , John G. Anderson , Scott J. MacGregor
Abstract: Disclosed herein are methods and devices for the inactivation of pathogens (e.g., bacteria, viruses, etc.) in ex vivo stored blood products, such as plasma and/or platelets, by means of directing visible light radiation from an illuminating device into blood product storage containers in order to achieve effective pathogen inactivation without the presence of an added photosensitising agent in the blood product. An exemplary apparatus includes a control unit that operates a light source that emits light in the wavelength region of about 380-500 nm which is directed onto blood product storage bags at sufficient intensity to penetrate the bag material and the opaque blood product therein in order to inactivate pathogens in the blood product but at dose levels that cause no significant detrimental effects on the blood product.
-
公开(公告)号:US20170246237A1
公开(公告)日:2017-08-31
申请号:US15517839
申请日:2015-10-09
Applicant: UNIVERSITY OF STRATHCLYDE
Inventor: Rein ULIJN , Tell TUTTLE , Pim FREDERIX , Gary SCOTT , Yousef ABUL-HAIJA
CPC classification number: A61K38/06 , A61K9/0014 , A61L15/60 , B82Y40/00 , C07K5/0812 , C07K5/0815 , G16B15/00
Abstract: The present invention relates to a method of predicting the propensity of tripeptides to from aggregates in solution. The present invention also provides tripeptides which are able to form aggregates in solution, as well as uses thereof. The present invention also provides nanostructures formed by self-aggregation of tripeptides of the present invention. The present invention also provides pH responsive aggregates as well as methods of screening for the ability of a tripeptide to form a pH dependent aggregate or gel.
-
公开(公告)号:US09598386B2
公开(公告)日:2017-03-21
申请号:US14420128
申请日:2013-07-25
Applicant: University of Strathclyde , University of Glasgow
Inventor: Margaret Harnett , William Harnett , Colin J. Suckling , Fraser Scott , Judith K. Huggan , Abedawn I. Khalaf
IPC: C07D295/088 , C07D207/06 , C07C317/28
CPC classification number: C07D295/088 , C07C317/28 , C07D207/06
Abstract: This invention relates to compounds and uses thereof in the treatment or prophylaxis of diseases associated with inflammation.
-
公开(公告)号:US20170014345A1
公开(公告)日:2017-01-19
申请号:US14977828
申请日:2015-12-22
Inventor: Barry Douglas Moore , Marie Claire Parker , Johann Partridge , Jan Vos , Michaela Maria Kreiner , Howard Norman Ernest Stevens , Maria Victoria Flores , Alistair Ross
CPC classification number: A61K9/1682 , A61K9/145 , A61K9/1617 , A61K9/1623 , A61K38/28 , A61K39/05 , A61K2039/55555 , Y02A50/466
Abstract: This invention relates to pharmaceutical formulations comprising particles with a substantially non-hygroscopic inner crystalline core and an outer coating comprising at least one bioactive molecule. The invention also relates to methods of forming particles comprising a substantially non-hygroscopic inner crystalline core and an outer coating comprising at least one bioactive molecule.
Abstract translation: 本发明涉及包含具有基本上非吸湿性内晶核的颗粒和包含至少一种生物活性分子的外涂层的药物制剂。 本发明还涉及形成包含基本上非吸湿性内晶核和包含至少一种生物活性分子的外涂层的颗粒的方法。
-
公开(公告)号:US20150182646A1
公开(公告)日:2015-07-02
申请号:US14657398
申请日:2015-03-13
Applicant: University of Strathclyde
Inventor: John Galloway Anderson , Michelle MacLean , Gerald Alexander Woolsey , Scott John MacGregor
IPC: A61L2/08
CPC classification number: A61L2/084 , A61L2/0052 , A61L9/18 , A61N5/06
Abstract: A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant Staphylococcus aureus (MRSA), Coagulase-Negative Staphylococcus (CONS), Streptococcus, Enterococcus and Clostridium species, comprising exposure to visible light, and in particular light within the wavelength range 400-500 nm.
Abstract translation: 一种灭活医学上重要的革兰氏阳性菌包括耐甲氧西林金黄色葡萄球菌(MRSA),凝固酶阴性葡萄球菌(CONS),链球菌,肠球菌和梭状芽孢杆菌属物种的方法,包括暴露于可见光,特别是在波长范围400内的光 -500nm。
-
公开(公告)号:US20020168414A1
公开(公告)日:2002-11-14
申请号:US10007257
申请日:2001-11-13
Applicant: University of Strathclyde
Inventor: Barry Douglas Moore , Marie Claire Parker , Peter James Halling , Johann Partridge
IPC: A61K009/16 , A61K009/50
Abstract: The present invention relates to protein-coated micro-crystals and their method of preparation. The protein-coated micro-crystals may find particular application in preparing enzymes for use as biocatalysts; preparation of therapeutic proteins for use in pharmaceutical formulations; production of cleansing agents comprising enzymes; production of paints, varnishes, coatings, films and the like comprising proteins which impart protective and/or antifouling properties; production of films, polymers, inks, coatings, electrodes and/or optical materials comprising proteins for diagnostic kits and/or biosensor applications; use of proteins for studies of molecular recognition, molecular binding and inhibitor binding in non-aqueous media; and preparation of protein based food additives.
Abstract translation: 本发明涉及蛋白质包被的微晶及其制备方法。 蛋白质包被的微晶可能特别适用于制备用作生物催化剂的酶; 用于药物制剂的治疗性蛋白质的制备; 生产包含酶的清洁剂; 制备包含赋予保护和/或防污性能的蛋白质的油漆,清漆,涂料,膜等; 生产包含用于诊断试剂盒和/或生物传感器应用的蛋白质的膜,聚合物,油墨,涂层,电极和/或光学材料; 使用蛋白质研究非水介质中的分子识别,分子结合和抑制剂结合; 和基于蛋白质的食品添加剂的制备。
-
公开(公告)号:US12138486B2
公开(公告)日:2024-11-12
申请号:US17762304
申请日:2020-09-25
Applicant: The University of Strathclyde
Inventor: Panagiotis Delinikolas , Bernhard Hidding , Fahim Ahmad Habib
Abstract: A medical system for providing radiotherapy is disclosed. The system comprises a particle accelerator configured to produce a radiation beam and irradiate at least a part of a subject with the radiation beam. The particle accelerator comprises a plasma zone comprising or configured to receive a plasma, and at least one beam source configured to provide an excitation beam along an axis through the plasma zone. The medical system is configured to provide a plurality of charged particles in the plasma in a region that propagates through the plasma zone behind the excitation beam such that the plurality of charged particles are accelerated to produce a radiation beam comprising the plurality of charged particles with a broadband energy distribution, wherein: at least part or all of the energy distribution of the radiation beam is substantially exponential or power-law; the radiation beam delivers 75% or more of a dose of the charged particles at and below 2 g/cm2; and/or the energy beam has an energy or energy distribution in the range from 10 eV to 10 MeV.
-
-
-
-
-
-
-
-
-